1. Ahmed MB, Islam SU, Sonn JK, Lee YS: PRP4 Kinase Domain Loss Nullifies Drug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells. Molecules and Cells 43: 662-670, 2020
2. ASCO (2008). Liver Cancer: Introduction. In Cancer.Net : Doctor-Appoved Patient Information from ASCO (American Society of Clinical Oncology), pp. The best cancer care starts with the best cancer information. With nearly 45,000 members who are leaders in advancing cancer care, the American Society of Clinical Oncology (ASCO) is the voice of the world’s cancer physicians. ASCO’s patient information website -- Cancer.Net (www.cancer.net) -- brings the expertise and resources of ASCO to people living with cancer and those who care for and care about them. Well-informed patients are their own best advocates and invaluable partners for physicians. Cancer.Net provides timely, comprehensive information to help patients and families make informed health care decisions.
Cancer.Net is supported by Conquer Cancer ® The ASCO Foundation.
3. Bertling E, Hotulainen P, Mattila PK, Matilainen T, Salminen M, Lappalainen P: Cyclase-associated protein 1 (CAP1) promotes cofilin-induced actin dynamics in mammalian nonmuscle cells. Mol Biol Cell 15: 2324-2334, 2004
4. Bid HK, Roberts RD, Manchanda PK, Houghton PJ: RAC1: an emerging therapeutic option for targeting cancer angiogenesis and
- 62 -
metastasis. Mol Cancer Ther 12: 1925-1934, 2013
5. Boureux A, Vignal E, Faure S, Fort P: Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol 24: 203-216, 2007 6. Bright MD, Clarke PA, Workman P, Davies FE: Oncogenic RAC1 and
NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling. Cell Signal 44: 127-137, 2018
7. Bustelo XR, Sauzeau V, Berenjeno IM: GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29: 356-370, 2007
8. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, Hirohashi S: Expression profiling in multistage hepatocarcinogenesis:
identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37: 198-207, 2003
9. Clarke HJ, Chambers JE, Liniker E, Marciniak SJ: Endoplasmic reticulum stress in malignancy. Cancer Cell 25: 563-573, 2014 10. Craene BD, Berx G: Regulatory networks defining EMT during
cancer initiation and progression. Nature Reviews Cancer 13: 97-110, 2013
11. Cubillos-Ruiz JR, Bettigole SE, Glimcher LH: Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer. Cell 168: 692-706, 2017
12. Dauer P, Sharma NS, Gupta VK, Durden B, Hadad R, Banerjee S, Dudeja V, Saluja A, Banerjee S: ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining "stemness". Cell Death Dis 10: 132, 2019 13. De P, Aske JC, Dey N: RAC1 Takes the Lead in Solid Tumors. Cell
- 63 - 8, 2019
14. Delorme V, Machacek M, DerMardirossian C, Anderson KL, Wittmann T, Hanein D, Waterman-Storer C, Danuser G, Bokoch GM:
Cofilin activity downstream of Pak1 regulates cell protrusion efficiency by organizing lamellipodium and lamella actin networks.
Dev Cell 13: 646-662, 2007
15. Dongre A, Weinberg RA: New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer.
Nature Reviews Molecular Cell Biology 20: 69-84, 2019
16. Ebi H, Costa C, Faber AC, Nishtala M, Kotani H, Juric D, Della Pelle P, Song Y, Yano S, Mino-Kenudson M, Benes CH, Engelman JA:
PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. PNAS 110: 21124-21129, 2013
17. Effendi K, Yamazaki K, Mori T, Masugi Y, Makino S, Sakamoto M:
Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression. Exp Cell Res 319: 35-44, 2013
18. Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today (Lyon, France, International Agency for Research on Cancer), pp. CANCER TODAY provides a suite of data visualization tools to explore estimates of the incidence, mortality, and prevalence of 36 specific cancer types and of all cancer sites combined in 185 countries or territories of the world in 2020, by sex and age group, as part of the GLOBOCAN project.
- 64 -
19. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B: Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87: 635-644, 2002 20. Fu J, Li M, Wu DC, Liu LL, Chen SL, Yun JP: Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma.
Translational Oncology 8: 400-406, 2015
21. Haga RB, Ridley AJ: Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases 7: 207-221, 2016
22. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA: AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67: 358-380, 2018
23. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW: Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J Cell Physiol 213:
374-383, 2007
24. Jee BA, Choi JH, Rhee H, Yoon S, Kwon SM, Nahm JH, Yoo JE, Jeon Y, Choi GH, Woo HG, Park YN: Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis. Cancer Res 79: 5500-5512, 2019
25. Jiang QH, Wang AX, Chen Y: Radixin enhances colon cancer cell invasion by increasing MMP-7 production via Rac1-ERK pathway.
The Scientific World Journal 2014: 340271, 2014
26. Jung H, Yoon SR, Lim J, Cho HJ, Lee HG: Dysregulation of Rho GTPases in Human Cancers. Cancers (Basel) 12, 2020
27. Kaufman RJ: Stress signaling from the lumen of the endoplasmic
- 65 -
reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13: 1211-1233, 1999
28. Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer KE, Furth EE, Viatour P: Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nature Communications 10: 1909, 2019
29. Kosmas K, Eskandarnaz A, Khorsandi AB, Kumar A, Ranjan R, Eming SA, Noegel AA, Peche VS: CAP2 is a regulator of the actin cytoskeleton and its absence changes infiltration of inflammatory cells and contraction of wounds. Eur J Cell Biol 94: 32-45, 2015 30. Lau E, Ronai ZA: ATF2 - at the crossroad of nuclear and cytosolic
functions. J Cell Sci 125: 2815-2824, 2012
31. Li D, Sedano S, Allen R, Gong J, Cho M, Sharma S: Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life. Cancers (Basel) 11, 2019
32. Lin CH, Shih CH, Lin YC, Yang YL, Chen BC: MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts. J Biomed Sci 25: 19, 2018
33. Lu W, Kang Y: Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. Dev Cell 49: 361-374, 2019
34. Madden E, Logue SE, Healy SJ, Manie S, Samali A: The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance. Biol Cell 111: 1-17, 2019
35. Mao J, Hu Y, Ruan L, Ji Y, Lou Z: Role of endoplasmic reticulum
- 66 -
stress in depression (Review). Mol Med Rep 20: 4774-4780, 2019 36. Marquardt JU, Andersen JB, Thorgeirsson SS: Functional and
genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer 15: 653-667, 2015
37. Meloche S, Pouyssegur J: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239, 2007
38. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209, 2005
39. Murphy LO, Blenis J: MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31: 268-275, 2006
40. Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY: Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 42: 809-818, 2005
41. Ojima H, Masugi Y, Tsujikawa H, Emoto K, Fujii-Nishimura Y, Hatano M, Kawaida M, Itano O, Kitagawa Y, Sakamoto M: Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions. Cancer Sci 107: 543-550, 2016
42. Ono S: The role of cyclase-associated protein in regulating actin filament dynamics - more than a monomer-sequestration factor. J Cell Sci 126: 3249-3258, 2013
43. Pang Y, Zhao Y, Wang Y, Wang X, Wang R, Liu N, Li P, Ji M, Ye J,
- 67 -
Sun T, Li J, Ma D, Lu F, Ji C: TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1. Journal of Experimental & Clinical Cancer Research 39: 158, 2020
44. Parri M, Chiarugi P: Rac and Rho GTPases in cancer cell motility control. Cell Communication and Signaling 8: 23, 2010
45. Ridley AJ: Rho GTPase signalling in cell migration. Curr Opin Cell Biol 36: 103-112, 2015
46. Roche J: The Epithelial-to-Mesenchymal Transition in Cancer.
Cancers (Basel) 10, 2018
47. Rogers SL, Wiedemann U, Stuurman N, Vale RD: Molecular requirements for actin-based lamella formation in Drosophila S2 cells. J Cell Biol 162: 1079-1088, 2003
48. Sakamoto M: Early HCC: diagnosis and molecular markers. Journal of Gastroenterology 44 Suppl 19: 108-111, 2009
49. Sakamoto M, Effendi K, Masugi Y: Molecular diagnosis of multistage hepatocarcinogenesis. Jpn J Clin Oncol 40: 891-896, 2010
50. Sakamoto M, Mori T, Masugi Y, Effendi K, Rie I, Du W: Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. Intervirology 51 Suppl 1: 42-45, 2008
51. Satelli A, Li S: Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046, 2011 52. Shibata R, Mori T, Du W, Chuma M, Gotoh M, Shimazu M, Ueda M,
Hirohashi S, Sakamoto M: Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin Cancer Res 12:
5363-5368, 2006
- 68 -
53. Shin S, Buel GR, Nagiec MJ, Han MJ, Roux PP, Blenis J, Yoon SO:
ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation. PNAS 116: 2967-2976, 2019
54. Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, Yamamoto N, Yamamoto M:
Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38: 605-614, 2003 55. Sisinni L, Pietrafesa M, Lepore S, Maddalena F, Condelli V, Esposito
F, Landriscina M: Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance. International Journal of Molecular Sciences 20, 2019
56. Smith BN, Bhowmick NA: Role of EMT in Metastasis and Therapy Resistance. J Clin Med 5, 2016
57. Spiering D, Hodgson L: Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr 5: 170-180, 2011 58. Steffen A, Ladwein M, Dimchev GA, Hein A, Schwenkmezger L,
Arens S, Ladwein KI, Margit Holleboom J, Schur F, Victor Small J, Schwarz J, Gerhard R, Faix J, Stradal TE, Brakebusch C, Rottner K:
Rac function is crucial for cell migration but is not required for spreading and focal adhesion formation. J Cell Sci 126: 4572-4588, 2013
59. Swiston J, Hubberstey A, Yu G, Young D: Differential expression of CAP and CAP2 in adult rat tissues. Gene 165: 273-277, 1995
- 69 -
60. Thomas PJ, Qu BH, Pedersen PL: Defective protein folding as a basis of human disease. Trends Biochem Sci 20: 456-459, 1995
61. Ueno A, Masugi Y, Yamazaki K, Kurebayashi Y, Tsujikawa H, Effendi K, Ojima H, Sakamoto M: Precision pathology analysis of the development and progression of hepatocellular carcinoma:
Implication for precision diagnosis of hepatocellular carcinoma.
Pathol Int 70: 140-154, 2020
62. Vandewynckel YP, Laukens D, Bogaerts E, Paridaens A, Van den Bussche A, Verhelst X, Van Steenkiste C, Descamps B, Vanhove C, Libbrecht L, De Rycke R, Lambrecht BN, Geerts A, Janssens S, Van Vlierberghe H: Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy. Hepatology International 9: 93-104, 2015
63. Wang M, Kaufman RJ: The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer 14: 581-597, 2014
64. Yadav RK, Chae SW, Kim HR, Chae HJ: Endoplasmic reticulum stress and cancer. Journal of Cancer Prevention 19: 75-88, 2014
65. Yamasaki T, Takahashi A, Pan J, Yamaguchi N, Yokoyama KK:
Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription. J Biol Chem 284: 8567-8581, 2009
66. Yamazaki K, Takamura M, Masugi Y, Mori T, Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S, Sakamoto M: Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved
- 70 -
in cancer cell motility. Lab Invest 89: 425-432, 2009
67. Yoon S, Choi JH, Kim SJ, Lee EJ, Shah M, Choi S, Woo HG: EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression. EMM 51: 1-12, 2019
68. Zeisberg M, Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437, 2009